Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 974-980

  Eneslätt, Kjell ^a   Rietz, Cecilia ^a,c   Rydén, Patrik ^a   Stöven, Svenja ^a   House, Robert V ^b   Wolfraim, Lawrence A ^b   Tärnvik, Arne ^a   Sjöstedt, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b A CSC Company   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Cell mediated immunity; Francisella tularensis; Persistence; Vaccination

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TULAREMIA VACCINE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FRANCISELLA TULARENSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TULAREMIA; VACCINATION;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; FRANCISELLA TULARENSIS; HUMANS; LYMPHOCYTES; MALE; VACCINES, ATTENUATED;

EID: 79953033206     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040923     Document Type: Article

References (23)

1. Burke, D. S., Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J. Infect. Dis. 1977. 135: 55-60.
2. Conlan, J. W. and Oyston, P. C., Vaccines against Francisella tularensis. Ann. N. Y. Acad. Sci. 2007. 1105: 325-350.
3. Kostiala, A. A., McGregor, D. D. and Logie, P. S., Tularaemia in the rat. I. The cellular basis on host resistance to infection. Immunology 1975. 28: 855-869.
4. Anthony, L. S. and Kongshavn, P. A., Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb. Pathog. 1987. 2: 3-14.
5. Ericsson, M., Sandstrom, G., Sjöstedt, A. and Tärnvik, A., Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J. Infect. Dis. 1994. 170: 110-114.
6. Anthony, L. S., Ghadirian, E., Nestel, F. P. and Kongshavn, P. A., The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb. Pathog. 1989. 7: 421-428.
7. Leiby, D. A., Fortier, A. H., Crawford, R. M., Schreiber, R. D. and Nacy, C. A., In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun. 1992. 60: 84-89.
8. Tärnvik, A., Löfgren, M. L., Löfgren, S., Sandström, G. and Wolf-Watz, H., Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine. J. Clin. Microbiol. 1985. 22: 527-530.
9. Piotrovskaia, S. A., Certain indices of immunity in children vaccinated against tularemia. Zh. Mikrobiol. Epidemiol. Immunobiol. 1958. 29: 129.
10. Paranavitana, C., Zelazowska, E., DaSilva, L., Pittman, P. R. and Nikolich, M., Th17 cytokines in recall responses against Francisella tularensis in humans. J. Interferon Cytokine Res. 2010. 30: 471-476.
11. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
12. Nakae, S., Iwakura, Y., Suto, H. and Galli, S. J., Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 2007. 81: 1258-1268.
13. Surcel, H. M., Syrjala, H., Karttunen, R., Tapaninaho, S. and Herva, E., Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia. Infect. Immun. 1991. 59: 1948-1953.
14. Gullberg, M., Ivars, F., Coutinho, A. and Larsson, E. L., Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures. J. Immunol. 1981. 127: 407-411.
15. Cantrell, D. A. and Smith, K. A., Transient expression of interleukin 2 receptors. Consequences for T cell growth. J. Exp. Med. 1983. 158: 1895-1911.
16. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
17. Steward-Tharp, S. M., Song, Y. J., Siegel, R. M. and O'Shea, J. J., New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression. Ann. N. Y. Acad. Sci. 2010. 1183: 123-148.
18. Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M. and Slifka, M. K., Duration of antiviral immunity after smallpox vaccination. Nat. Med. 2003. 9: 1131-1137.
19. Naniche, D., Garenne, M., Rae, C., Manchester, M., Buchta, R., Brodine, S. K. and Oldstone, M. B., Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. J. Infect. Dis. 2004. 190: 1387-1395.
20. Boyman, O., Letourneau, S., Krieg, C. and Sprent, J., Homeostatic proliferation and survival of naive and memory T cells. Eur. J. Immunol. 2009. 39: 2088-2094.
21. Sansoni, P., Vescovini, R., Fagnoni, F., Biasini, C., Zanni, F., Zanlari, L., Telera, A. et al., The immune system in extreme longevity. Exp. Gerontol. 2008. 43: 61-65.
22. Sansoni, P., Fagnoni, F., Vescovini, R., Mazzola, M., Brianti, V., Bologna, G., Nigro, E. et al., T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians. Mech. Ageing Dev. 1997. 96: 127-136.
23. Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol. Rec. 1995. 70: 229-231.